Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

References

• Abaan OD, Mutlu PK, Baran Y, Atalay C, Gunduz U. 2009. Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients. Cancer Invest. 27:201–205.
   PubMed Web of Science ®Google Scholar
• Abla N, Chinn LW, Nakamura T, Liu L, Huang CC, Johns SJ, Kawamoto M, Stryke D, Taylor TR, Ferrin TE, et al. 2008. The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene. J Pharmacol Exp Ther. 325:859–868.
   PubMed Web of Science ®Google Scholar
• Abreu AC, Serra SC, Borges A, Saavedra MJ, Mcbain AJ, Salgado AJ, Simões M. 2015. Combinatorial activity of flavonoids with antibiotics against drug-resistant Staphylococcus aureus. Microb Drug Resist. 21:600–609.
   PubMed Web of Science ®Google Scholar
• Adachi M, Sampath J, Lan L, Sun D, Hargrove P, Flatley R, Tatum A, Edwards MZ, Wezeman M, Matherly L. 2002. Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing. J Biol Chem. 277:38998–39004.
   PubMed Web of Science ®Google Scholar
• Agustiandari H, Lubelski J, Saparoea HV, Kuipers OP, Driessen A. 2008. LmrR is a transcriptional repressor of expression of the multidrug ABC transporter LmrCD in Lactococcus lactis. J Bacteriol. 190:759–763.
   PubMed Web of Science ®Google Scholar
• Aínsa JA, Blokpoel MC, Otal I, Young DB, De Smet KA, Martín C. 1998. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol. 180:5836–5843.
   PubMed Web of Science ®Google Scholar
• Al-Karablieh N, Weingart H, Ullrich MS. 2009. Genetic exchange of multidrug efflux pumps among two enterobacterial species with distinctive ecological niches. Int J Mol Sci. 10:629–645.
   PubMed Web of Science ®Google Scholar
• Aller SG, Yu J, Ward A, Weng Y, Chittaboina S, Zhuo R, Harrell PM, Trinh YT, Zhang Q, Urbatsch IL, et al. 2009. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science. 323:1718–1722.
   PubMed Web of Science ®Google Scholar
• Alonso A, Martinez JL. 2001. Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 45:1879–1881.
   PubMed Web of Science ®Google Scholar
• Amaral L, Spengler G, Martins A, Armada A, Handzlik J, Kiec-Kononowicz K, Molnar J. 2012. Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cells. Anticancer Res. 32:2947–2957.
   PubMed Web of Science ®Google Scholar
• Annilo T, Chen ZQ, Shulenin S, Costantino J, Thomas L, Lou H, Stefanov S, Dean M. 2006. Evolution of the vertebrate ABC gene family: analysis of gene birth and death. Genomics. 88:1–11.
   PubMed Web of Science ®Google Scholar
• Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM. 2015. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arch Iran Med. 18:102–108.
   PubMed Web of Science ®Google Scholar
• Askoura M, Mottawea W, Abujamel T, Taher I. 2011. Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa. Libyan J Med. 6:1–8.
   Web of Science ®Google Scholar
• Austin Doyle L, Ross DD. 2003. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 22:7340–7358.
   PubMed Web of Science ®Google Scholar
• Bai J, Lai L, Yeo HC, Goh BC, Tan T. 2004. Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione. Int J Biochem Cell Biol. 36:247–257.
   PubMed Web of Science ®Google Scholar
• Balganesh M, Dinesh N, Sharma S, Kuruppath S, Nair AV, Sharma U. 2012. Efflux pumps of Mycobacterium tuberculosis play a significant role in anti-tuberculosis activity of potential drug candidates. Antimicrob Agents Chemother. 56:2643–2651.
   PubMed Web of Science ®Google Scholar
• Balganesh M, Kuruppath S, Marcel N, Sharma S, Nair A, Sharma U. 2010. Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery. Antimicrob Agents Chemother. 54:5167–5172.
   PubMed Web of Science ®Google Scholar
• Banerjee D, Sengupta S. 2011. Nanoparticles in cancer chemotherapy. Prog Mol Biol Transl Sci. 104:489–507.
   PubMed Web of Science ®Google Scholar
• Bao L, Haque A, Jackson K, Hazari S, Moroz K, Jetly R, Dash S. 2011. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am J Pathol. 178:838–852.
   PubMed Web of Science ®Google Scholar
• Bay DC, Rommens KL, Turner RJ. 2008. Small multidrug resistance proteins: a multidrug transporter family that continues to grow. Biochim Biophys Acta – Biomembr. 1778:1814–1838.
   PubMed Web of Science ®Google Scholar
• Beedholm-Ebsen R, Van De Wetering K, Hardlei T, Nexø E, Borst P, Moestrup SK. 2010. Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood. 115:1632–1639.
   PubMed Web of Science ®Google Scholar
• Bennis S, Chapey C, Robert J, Couvreur P. 1994. Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture. Eur J Cancer. 30:89–93.
   Web of Science ®Google Scholar
• Beretta GL, Benedetti V, Cossa G, Assaraf YGA, Bram E, Gatti L, Corna E, Carenini N, Colangelo D, Howell SB, et al. 2010. Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. Biochem Pharmacol. 79:1108–1117.
   PubMed Web of Science ®Google Scholar
• Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. 2002. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 302:645–650.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya T, Sharma A, Akhter J, Pathania R. 2017. The small molecule IITR08027 restores the antibacterial activity of fluoroquinolones against multidrug-resistant Acinetobacter baumannii by efflux inhibition. Int J Antimicrob Agents. 50:219–226.
   PubMed Web of Science ®Google Scholar
• Bialek-Davenet S, Lavigne JP, Guyot K, Mayer N, Tournebize R, Brisse S, Leflon-Guibout V, Nicolas-Chanoine MH. 2015. Differential contribution of AcrAB and OqxAB efflux pumps to multidrug resistance and virulence in Klebsiella pneumoniae. J Antimicrob Chemother. 70:81–88.
   PubMed Web of Science ®Google Scholar
• Blackmore CG, Peter AM, Veen HV. 2001. Multidrug transporters in prokaryotic and eukaryotic cells : physiological functions and transport mechanisms. Mol Membr Biol. 18(1):97–103.
   Google Scholar
• Borges-Walmsley MI, McKeegan KS, Walmsley AR. 2003. Structure and function of efflux pumps that confer resistance to drugs. Biochem J. 376:313–338.
   PubMed Web of Science ®Google Scholar
• Borst P, Evers R, Kool M, Wijnholds J. 2000a. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 92:1295–1302.
   PubMed Web of Science ®Google Scholar
• Borst P, Zelcer N, Van Helvoort A. 2000b. ABC transporters in lipid transport. Biochim Biophys Acta. 1486:128–144.
   PubMed Web of Science ®Google Scholar
• Boumendjel A, Macalou S, Valdameri G, Pozza A, Gauthier C, Arnaud O, Nicolle E, Magnard S, Falson P, Terreux R, et al. 2011. Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation. Curr Med Chem. 18:3387–3401.
   PubMed Web of Science ®Google Scholar
• Boumendjel A, Mcleer-Florin A, Champelovier P, Allegro D, Muhammad D, Souard F, Derouazi M, Peyrot V, Toussaint B, Boutonnat J, et al. 2009. A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models. BMC Cancer. 9:242.
   PubMed Web of Science ®Google Scholar
• Brigger I, Dubernet C, Couvreur P. 2002. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 54:631–651.
   PubMed Web of Science ®Google Scholar
• Brincat JP, Broccatelli F, Sabatini S, Frosini M, Neri A, Kaatz GW, Cruciani G, Carosati E. 2012. Ligand promiscuity between the efflux pumps human P-glycoprotein and S. aureus NorA. ACS Med Chem Lett. 3:248–251.
   PubMed Web of Science ®Google Scholar
• Brown MH, Skurray RA. 2001. Staphylococcal multidrug efflux protein QacA. J Mol Microbiol Biotechnol. 3:163–170.
   PubMed Web of Science ®Google Scholar
• Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino BP. 1998. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood. 92:2269–2279.
   PubMed Web of Science ®Google Scholar
• Chen HH, Huang WC, Chiang WH, Liu TI, Shen MY, Hsu YH, Lin SC, Chiu HC. 2015. Ph-responsive therapeutic solid lipid nanoparticles for reducing P-glycoprotein-mediated drug efflux of multidrug resistant cancer cells. Int J Nanomedicine. 10:5035–5048.
   PubMed Web of Science ®Google Scholar
• Christena LR, Mangalagowri V, Pradheeba P, Ahmed KBA, Shalini BIS, Vidyalakshmi M, Anbazhagan V, Sai subramanian N. 2015. Copper nanoparticles as an efflux pump inhibitor to tackle drug resistant bacteria. RSC Adv. 5:12899–12909.
   Web of Science ®Google Scholar
• Christena LR, Raman T, Makala VH, Ulaganathan V, Subramaniapillai S. 2016. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail Multi Drug Resistant clinical isolate of MRSA in a zebra fish infection model. Appl Microbiol Biotechnol. 100:9265–9281.
   PubMed Web of Science ®Google Scholar
• Christena LR, Subramaniam S, Vidhyalakshmi M, Mahadevan V, Sivasubramanian A, Nagarajan S. 2015. Dual role of pinostrobin-a flavonoid nutraceutical as an efflux pump inhibitor and antibiofilm agent to mitigate food borne pathogens. RSC Adv. 5:61881–61887.
   Web of Science ®Google Scholar
• Chusri S, Siriyong T, Voravuthikunchai SP, Tipmanee V, Srimanote P. 2016. Holarrhena antidysenterica extract and its steroidal alkaloid, conessine, as resistance-modifying agents against extensively drug-resistant Acinetobacter baumannii. Microb Drug Resist. 22:273–282.
   PubMed Web of Science ®Google Scholar
• Coelho, A C, Messier, N, Ouellette, M, Cotrim, P C. 2007. Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes. Antimicrob Agents Chemother.51:3030–3032. 17452480 10.1128/AAC.00404-07
   PubMed Web of Science ®Google Scholar
• Coelho MLV, Coutinho BG, Cabral da Silva Santos O, Nes IF, Bastos Mdo C. 2014. Immunity to the Staphylococcus aureus leaderless four-peptide bacteriocin aureocin A70 is conferred by AurI, an integral membrane protein. Res Microbiol. 165:50–59.
   PubMed Web of Science ®Google Scholar
• Collins B, Curtis N, Cotter PD, Hill C, Ross RP. 2010. The ABC transporter, AnrAB, contributes to the innate resistance of Listeria monocyctogenes to nisin, bacitracin and various beta-lactam antibiotics. Antimicrob Agents Chemother. 54:4416–4423.
   PubMed Web of Science ®Google Scholar
• Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, Gentile M, Cianfriglia M, Ciervo A, Caraglia M, Budillon A, et al. 2008. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol. 128:957–971.
   PubMed Web of Science ®Google Scholar
• Costa SS, Viveiros M, Amaral L, Couto I. 2013. Multidrug efflux pumps in Staphylococcus aureus: an update. Open Microbiol J. 7:59–71.
   PubMedGoogle Scholar
• Dallas S, Miller DS, Bendayan R. 2006. Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol Rev. 58:140–161.
   PubMed Web of Science ®Google Scholar
• Dantas N, de Aquino TM, de A, Junior JX, da Silva-Junior E, Gomes EA, Gomes AAS, Siqueira-Junior JP, Mendonca Junior F. 2018. Aminoguanidine Hydrazones (AGH's) as modulators of modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump. Chem Biol Interact. 280:8–14.
   PubMed Web of Science ®Google Scholar
• Dassa E, Bouige P. 2001. The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms. Res Microbiol. 152:211–229.
   PubMed Web of Science ®Google Scholar
• Datta A, Bhasin N, Kim H, Ranjan M, Rider B, Abd Elmageed ZY, Mondal D, Agrawal KC, Abdel-Mageed AB. 2015. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells. Cancer Lett. 362:25–35.
   PubMed Web of Science ®Google Scholar
• Davidson AL, Dassa E, Orelle C, Chen J. 2008. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev. 72:317–364.
   PubMed Web of Science ®Google Scholar
• Dawson RJP, Locher KP. 2006. Structure of a bacterial multidrug ABC transporter. Nature. 443:180–185.
   PubMed Web of Science ®Google Scholar
• Dawson RJP, Locher KP. 2007. Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lett. 581:935–938.
   PubMed Web of Science ®Google Scholar
• Deeley RG, Cole SP. 1997. Function, evolution and structure of multidrug resistance protein (MRP). Semin Cancer Biol. 8:193–204.
   PubMed Web of Science ®Google Scholar
• Deeley RG, Cole S. 2006. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580:1103–1111.
   PubMed Web of Science ®Google Scholar
• de Verdière AC, Dubernet C, Nemati F, Poupon MF, Puisieux F, Couvreur P. 1994. Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother Pharmacol. 33:504–508.
   PubMed Web of Science ®Google Scholar
• de Waart DR, Paulusma CC, Kunne C, Oude Elferink R. 2006. Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. Liver Int. 26:362–368.
   PubMed Web of Science ®Google Scholar
• Diao L, Li N, Brayman TG, Hotz KJ, Lai Y. 2010. Regulation of MRP2/ABCC2 and BSEP/ABCB11 expression in sandwich cultured human and rat hepatocytes exposed to inflammatory cytokines TNF-{alpha}, IL-6, and IL-1{beta}. J Biol Chem. 285:31185–31192.
   PubMed Web of Science ®Google Scholar
• Ding R, Jin S, Pabon K, Scotto KW. 2016. A role for ABCG2 beyond drug transport: regulation of autophagy. Autophagy. 12:737–751.
   PubMed Web of Science ®Google Scholar
• Ding Y, Onodera Y, Lee JC, Hooper DC. 2008. NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J Bacteriol. 190:7123–7129.
   PubMed Web of Science ®Google Scholar
• Duan Z, Brakora K, Seiden MV. 2004. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. Mol Cancer Ther. 3:833.
   PubMed Web of Science ®Google Scholar
• Dymek A, Armada A, Handzlik J, Viveiros M, Spengler G, Molnar J, Kieć-Kononowicz K, Amaral L. 2012. The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus. In Vivo. 26:223–229.
   PubMed Web of Science ®Google Scholar
• Eid SY, El-Readi MZ, Ashour ML, Wink M. 2015. Fallopia japonica, a natural modulator, can overcome multidrug resistance in cancer cells. Evid Based Complement Alternat Med. 2015:868424.
   PubMedGoogle Scholar
• Evers R, Cnubben NH, Wijnholds J, van Deemter L, van Bladeren PJ, Borst P. 1997. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1. FEBS Lett. 419:112–116.
   PubMed Web of Science ®Google Scholar
• Falasca M, Linton KJ. 2012. Investigational ABC transporter inhibitors. Expert Opin Investig Drugs. 21:657–666.
   PubMed Web of Science ®Google Scholar
• Faneyte IF, Kristel PMP, van de Vijver MJ. 2004. Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer. Anticancer Res. 24:2931–2939.
   PubMed Web of Science ®Google Scholar
• Fischer S, Klüver N, Burkhardt-Medicke K, Pietsch M, Schmidt A-M, Wellner P, Schirmer K, Luckenbach T, Gottesman M, Ambudkar S. 2013. ABCB4 acts as multixenobiotic transporter and active barrier against chemical uptake in zebrafish (Danio rerio) embryos. BMC Biol. 11:69.
   PubMed Web of Science ®Google Scholar
• Fletcher JI, Haber M, Henderson MJ, Norris MD. 2010. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 10:147–156.
   PubMed Web of Science ®Google Scholar
• Floyd JL, Smith KP, Kumar SH, Floyd JT, Varela MF. 2010. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agents Chemother. 54:5406–5412.
   PubMed Web of Science ®Google Scholar
• Fontaine F, Hequet A, Bouillon A, Cresteil T, Jolivalt C, Rault S. 2013. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. J Med Chem. 57:2536–2548.
   Web of Science ®Google Scholar
• Fukuda Y, Schuetz JD. 2012. ABC transporters and their role in nucleoside and nucleotide drug resistance. Biochem Pharmacol. 83:1073–1083.
   PubMed Web of Science ®Google Scholar
• Gabriella S, Ákos Csonka JM, Amaral L. 2016. The anticancer activity of the old neuroleptic phenothiazine-type drug thioridazine. Anticancer Res. 5706:5701–5706.
   Google Scholar
• Ganesan A, Christena LR, Venkata Subbarao HM, Venkatasubramanian U, Thiagarajan R, Sivaramakrishnan V, Kasilingam K, Saisubramanian N, Selva Ganesan S. 2016. Identification of benzochromene derivatives as a highly specific NorA efflux pump inhibitor to mitigate the drug resistant strains of S. aureus. RSC Adv. 6:30258–30267.
   Web of Science ®Google Scholar
• El Garch F, Lismond A, Piddock LV, Courvalin P, Tulkens PM, van Bambeke F. 2010. Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. J Antimicrob Chemother. 65:2076–2082.
   PubMed Web of Science ®Google Scholar
• Garvey MI, Piddock LV. 2008. The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB. Antimicrob Agents Chemother. 52:1677–1685.
   PubMed Web of Science ®Google Scholar
• Garvey MI, Rahman MM, Gibbons S, Piddock LV. 2011. Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria. Int J Antimicrob Agents. 37:145–151.
   PubMed Web of Science ®Google Scholar
• German N, Wei P, Kaatz GW, Kerns RJ. 2008. Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumps. Eur J Med Chem. 43:2453–2463.
   PubMed Web of Science ®Google Scholar
• Gibbons S, Oluwatuyi M, Kaatz GW. 2003. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother. 51:13–17.
   PubMed Web of Science ®Google Scholar
• Golparian D, Shafer WM, Ohnishi M, Unemo M. 2014. Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 58:3556–3559.
   PubMed Web of Science ®Google Scholar
• Gong J, Luk F, Jaiswal R, George AM, Grau GER, Bebawy M. 2013. Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance. Eur J Pharmacol. 721:116–125.
   PubMed Web of Science ®Google Scholar
• Gorle S, Maddila S, Maddila S, Naicker K, Singh M, Singh P, Jonnalagadda S. 2017. Synthesis, molecular docking study and in vitro anticancer activity of tetrazole linked benzochromene derivatives. Anticancer Agents Med Chem. 17:464–470.
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Fojo T, Bates SE. 2002. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2:48–58.
   PubMed Web of Science ®Google Scholar
• Gruenert DC, Willems M, Cassiman JJ, Frizzell RA. 2004. Established cell lines used in cystic fibrosis research. J Cyst Fibros. 3:191–196.
   PubMedGoogle Scholar
• Gu X, Ren Z, Peng H, Peng S, Zhang Y. 2014. Bifendate-chalcone hybrids: a new class of potential dual inhibitors of P-glycoprotein and breast cancer resistance protein. Biochem Biophys Res Commun. 455:318–322.
   PubMed Web of Science ®Google Scholar
• Guay GG, Rothstein DM. 1993. Expression of the TetK gene from Staphylococcus aureus in Escherichia coli: comparison of substrate specificities of TetA(B), TetA(C), and TetK efflux proteins. Antimicrob Agents Chemother. 37:191–198.
   PubMed Web of Science ®Google Scholar
• Handzlik J, Szymańska E, Chevalier J, Otrębska E, Kieć-Kononowicz K, Pagès J-M, Alibert S. 2011. Amine-alkyl derivatives of hydantoin: new tool to combat resistant bacteria. Eur J Med Chem. 46:5807–5816.
   PubMed Web of Science ®Google Scholar
• Hediger MA, Romero MF, Peng J-B, Rolfs A, Takanaga H, Bruford EA. 2004. The ABCs of solute carriers : physiological, pathological and therapeutic implications of human membrane transport proteins. Eur J Physiol. 447:465–468.
   PubMed Web of Science ®Google Scholar
• Heimerl S, Bosserhoff AK, Langmann T, Ecker J, Schmitz G. 2007. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res. 17:265–273.
   PubMed Web of Science ®Google Scholar
• Hirano M, Maeda K, Hayashi H, Kusuhara H, Sugiyama Y. 2005. Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther. 314:876–882.
   PubMed Web of Science ®Google Scholar
• Hiron A, Falord M, Valle J, Débarbouillé M, Msadek T. 2011. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol Microbiol. 81:602–622.
   PubMed Web of Science ®Google Scholar
• Holler JG, Slotved H-C, Mølgaard P, Olsen CE, Christensen SB. 2012. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. Bioorg Med Chem. 20:4514–4521.
   PubMed Web of Science ®Google Scholar
• Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. 2013. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 13:714–726.
   PubMed Web of Science ®Google Scholar
• Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S. 2014. Drug resistance in cancer: an overview. Cancers. 6:1769–1792.
   PubMed Web of Science ®Google Scholar
• Huang TS, Kunin CM, Wang HM, Yan BS, Huang SP, Chen YS, Shin-Jung Lee S, Syu WJ. 2013. Inhibition of the Mycobacterium tuberculosis reserpine-sensitive efflux pump augments intracellular concentrations of ciprofloxacin and enhances susceptibility of some clinical isolates. J Formos Med Assoc. 112:789–794.
   PubMed Web of Science ®Google Scholar
• Huda MN, Chen J, Morita Y, Kuroda T, Mizushima T, Tsuchiya T. 2003. Gene cloning and characterization of VcrM, a Na+-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol Immunol. 47:419–427.
   PubMed Web of Science ®Google Scholar
• Huda MN, Morita Y, Kuroda T, Mizushima T, Tsuchiya T. 2001. Na+-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol Lett. 203:235–239.
   PubMed Web of Science ®Google Scholar
• Jaiswal R, Gong J, Sambasivam S, Combes V, Mathys J-M, Davey R, Grau GER, Bebawy M. 2012. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J. 26:420–429.
   PubMed Web of Science ®Google Scholar
• Jonsson I-M, Juuti JT, François P, AlMajidi R, Pietiäinen M, Girard M, Lindholm C, Saller MJ, Driessen AJM, Kuusela P, et al. 2010. Inactivation of the Ecs ABC transporter of Staphylococcus aureus attenuates virulence by altering composition and function of bacterial wall. PLoS One. 5:e14209.
   PubMed Web of Science ®Google Scholar
• Joshi P, Singh S, Wani A, Sharma S, Jain SK, Singh B, Gupta BD, Satti NK, Koul S, Khan IA, et al. 2014. Osthol and curcumin as inhibitors of human P-gp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs. Med Chem Commun. 5:1540–1547.
   Google Scholar
• Jungwirth H, Kuchler K. 2006. Yeast ABC transporters – a tale of sex, stress, drugs and aging. FEBS Lett. 580:1131–1138.
   PubMed Web of Science ®Google Scholar
• Kaatz GW, Moudgal VV, Seo SM, Kristiansen JE. 2003. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob Agents Chemother. 47:719–726.
   PubMed Web of Science ®Google Scholar
• Kaliszczak M, Antonow D, Patel KI, Howard P, Jodrell DI, Thurston DE, Guichard SM. 2010. Optimization of the antitumor activity of sequence-specific pyrrolobenzodiazepine derivatives based on their affinity for ABC transporters. AAPS J. 12:617–627.
   PubMed Web of Science ®Google Scholar
• Kaye SB. 2008. Reversal of drug resistance in ovarian cancer: where do we go from here? J Clin Oncol. 26:2616–2618.
   PubMed Web of Science ®Google Scholar
• Khan IA, Mirza ZM, Kumar A, Verma V, Qazi GN. 2006. Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus. Antimicrob Agents Chemother. 50:810–812.
   PubMed Web of Science ®Google Scholar
• Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullén A, et al. 2015. Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget. 6:21740–21754.
   PubMed Web of Science ®Google Scholar
• Kheirollahi A, Pordeli M, Safavi M, Mashkouri S, Naimi-Jamal MR, Ardestani SK. 2014. Cytotoxic and apoptotic effects of synthetic benzochromene derivatives on human cancer cell lines. Naunyn Schmiedebergs Arch Pharmacol. 387:1199–1208.
   PubMed Web of Science ®Google Scholar
• Kim M, Turnquist H, Jackson J, Sgagias M, Yan Y, Gong M, Dean M, Sharp JG, Cowan K. 2002. The multidrug resistance transporter ABCG2 (Breast Cancer Resistance Protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res. 8:22–28.
   PubMed Web of Science ®Google Scholar
• Kim MK, Kim Y, Choo H, Chong Y. 2017. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein. Bioorg Med Chem. 25:1219–1226.
   PubMed Web of Science ®Google Scholar
• Kiran MD, Akiyoshi DE, Giacometti A, Cirioni O, Scalise G, Balaban N. 2009. OpuC-an ABC transporter that is associated with Staphylococcus aureus pathogenesis. Int J Artif Organs. 32:600–610.
   PubMed Web of Science ®Google Scholar
• Klein JS, Lewinson O. 2011. Bacterial ATP-driven transporters of transition metals : physiological roles, mechanisms of action, and roles in bacterial virulence. Metallomics. 3:1098–1108.
   PubMed Web of Science ®Google Scholar
• König J, Hartel M, Nies AT, Martignoni ME, Guo J, Büchler MW, Friess H, Keppler D. 2005. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer. 115:359–367.
   PubMed Web of Science ®Google Scholar
• König J, Müller F, Fromm MF. 2013. Transporters and drug–drug interactions: important determinants of drug disposition and effects. Pharmacol Rev. 65:944–966.
   PubMed Web of Science ®Google Scholar
• Kort A, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH. 2015. Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2). Pharmacol Res. 102:200–207.
   PubMed Web of Science ®Google Scholar
• Kristiansen MM, Leandro C, Ordway D, Martins M, Viveiros M, Pacheco T, Molnar J, Kristiansen JE, Amaral L. 2006. Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump. In Vivo. 20:361–366.
   PubMed Web of Science ®Google Scholar
• Kumar A, Khan IA, Koul S, Koul JL, Taneja SC, Ali I, Ali F, Sharma S, Mirza ZM, Kumar M, et al. 2008. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother. 61:1270–1276.
   PubMed Web of Science ®Google Scholar
• Kuroda T, Tsuchiya T. 2009. Multidrug efflux transporters in the MATE family. Biochim Biophys Acta – Proteins Proteomics. 1794:763–768.
   PubMed Web of Science ®Google Scholar
• Lamers RP, Cavallari JF, Burrows LL. 2013. The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of Gram-negative bacteria. PLoS One. 8:e60666.
   PubMed Web of Science ®Google Scholar
• Larsen AK, Escargueil AE, Skladanowski A. 2000. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther. 85:217–229.
   PubMed Web of Science ®Google Scholar
• Lee E, Huda MN, Kuroda T, Mizushima T, Tsuchiya T. 2003. EfrAB, an ABC multidrug efflux pump in Enteroccus faecalis. Am Soc Microbiol. 47:3733–3738.
   Google Scholar
• Lee EH, Shafer WM. 1999. The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids. Mol Microbiol. 33:839–845.
   PubMed Web of Science ®Google Scholar
• Leitner HM, Kachadourian R, Day BJ. 2007. Harnessing drug resistance: using ABC transporter proteins to target cancer cells. Biochem Pharmacol. 74:1677–1685.
   PubMed Web of Science ®Google Scholar
• Leitner I, Nemeth J, Feurstein T, Abrahim A, Matzneller P, Lagler H, Erker T, Langer O, Zeitlinger M. 2011. The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration. J Antimicrob Chemother. 66:834–839.
   PubMed Web of Science ®Google Scholar
• Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 10:S122–S129.
   PubMed Web of Science ®Google Scholar
• Le Vee M, Jigorel E, Glaise D, Gripon P, Guguen-Guillouzo C, Fardel O. 2006. Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur J Pharm Sci. 28:109–117.
   PubMed Web of Science ®Google Scholar
• Lhommé C, Joly F, Walker JL, Lissoni AA, Nicoletto MO, Manikhas GM, Baekelandt MMO, Gordon AN, Fracasso PM, Mietlowski WL, et al. 2008. Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer. J Clin Oncol. 26:2674–2682.
   PubMed Web of Science ®Google Scholar
• Li S, Lei Y, Jia Y, Li N, Wink M, Ma Y. 2011. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine. 19:83–87.
   PubMed Web of Science ®Google Scholar
• Li X-Z, Poole K, Nikaido H. 2003. Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob Agents Chemother. 7:27–33.
   Google Scholar
• Limaverde PW, Campina FF, da Cunha FAB, Crispim FD, Figueredo FG, Lima LF, Datiane de M. Oliveira-Tintino C, de Matos YMLS, Morais-Braga MFB, Menezes IRA, et al. 2017. Inhibition of the TetK efflux-pump by the essential oil of Chenopodium ambrosioides L. and α-terpinene against Staphylococcus aureus IS-58. Food Chem Toxicol. 109:957–961. .
   PubMed Web of Science ®Google Scholar
• Limtrakul P, Khantamat O, Pintha K. 2005. Inhibition of P-glycoprotein function and expression by kaempferol and ouercetin. J Chemother. 17:86–95.
   PubMed Web of Science ®Google Scholar
• Lin F, He Z, Hu B, Tang L, Zheng S, Sun Y, Sheng Z, Yao Y. 2015. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells. J Can Res Ther. 11:18.
   PubMed Web of Science ®Google Scholar
• Lomovskaya O, Bostian KA. 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic – a vision for applied use. Biochem Pharmacol. 71:910–918.
   PubMed Web of Science ®Google Scholar
• Long F, Rouquette-Loughlin C, Shafer WM, Yu EW. 2008. Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli. Antimicrob Agents Chemother. 52:3052–3060.
   PubMed Web of Science ®Google Scholar
• Loo TW, Bartlett MC, Clarke DM. 2003. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein. J Biol Chem. 278:39706–39710.
   PubMed Web of Science ®Google Scholar
• Lubelski J, Jong A, De Merkerk R, Van Agustiandari H, Kuipers OP, Kok J, Driessen A. 2006. LmrCD is a major multidrug resistance transporter in Lactococcus lactis. Mol Microbiol. 61:771–781.
   PubMed Web of Science ®Google Scholar
• Lv L, Liu C, Chen C, Yu X, Chen G, Shi Y, Qin F, Ou J, Qiu K, Li G. 2016. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer. Oncotarget. 7:32184–32199.
   PubMedGoogle Scholar
• Mao Q, Unadkat JD. 2005. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J. 7:E118–E133.
   PubMed Web of Science ®Google Scholar
• Mao Q, Unadkat JD. 2015. Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport - An update. AAPS J. 17:65–82.
   PubMed Web of Science ®Google Scholar
• Margolles A, Putman M, van Veen HW, Konings WN. 1999. The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids. Biochemistry. 38:16298–16306.
   PubMed Web of Science ®Google Scholar
• Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY. 2013. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv Drug Deliv Rev. 65:1866–1879.
   PubMed Web of Science ®Google Scholar
• Marquez B. 2005. Bacterial efflux systems and efflux pumps inhibitors. Biochimie. 87:1137–1147.
   PubMed Web of Science ®Google Scholar
• Marrer E, Schad K, Satoh AT, Page MGP, Johnson MM, Piddock LV. 2006. Involvement of the putative ATP-dependent efflux proteins PatA and PatB in fluoroquinolone resistance of a multidrug-resistant mutant of Streptococcus pneumoniae. Antimicrob Agents Chemother. 50:685–693.
   PubMed Web of Science ®Google Scholar
• Martinez JL, Sánchez MB, Martínez-Solano L, Hernandez A, Garmendia L, Fajardo A, Alvarez-Ortega C. 2009. Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev. 33:430–449.
   PubMed Web of Science ®Google Scholar
• Mata MT, Baquero F, Perez DJ. 2000. A multidrug efflux transporter in Listeria monocytogenes. FEMS Microbiol Lett. 187:185–188.
   PubMed Web of Science ®Google Scholar
• Matsuo T, Chen J, Minato Y, Ogawa W, Mizushima T, Kuroda T, Tsuchiya T. 2008. SmdAB, a heterodimeric ABC-type multidrug efflux pump, in Serratia marcescens. J Bacteriol. 190:648–654.
   PubMed Web of Science ®Google Scholar
• Mazurkiewicz P, Konings WN, Poelarends GJ. 2002. Acidic residues in the lactococcal multidrug efflux pump LmrP play critical roles in transport of lipophilic cationic compounds. J Biol Chem. 277:26081–26088.
   PubMed Web of Science ®Google Scholar
• Meehl M, Herbert S, Götz F, Cheung A. 2007. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 51:2679–2689.
   PubMed Web of Science ®Google Scholar
• Miletti-Gonzalez KE, Chen S, Muthukumaran N, Saglimbeni GN, Wu X, Yang J, Apolito K, Shih WJ, Hait WN, Rodríguez-Rodríguez L. 2005. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 65:6660–6667.
   PubMed Web of Science ®Google Scholar
• Mirza ZM, Kumar A, Kalia NP, Zargar A, Khan IA. 2011. Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus. J Med Microbiol. 60:1472–1478.
   PubMed Web of Science ®Google Scholar
• Mohana S, Ganesan M, Agilan B, Karthikeyan R, Srithar G, Beaulah Mary R, Ananthakrishnan D, Velmurugan D, Rajendra Prasad N, Ambudkar SV. 2016. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mol Biosyst. 12:2458–2470.
   PubMed Web of Science ®Google Scholar
• Montanari F, Ecker GF. 2015. Prediction of drug-ABC-transporter interaction – recent advances and future challenges. Adv Drug Deliv Rev. 86:17–26.
   PubMed Web of Science ®Google Scholar
• Morita SY, Terada T. 2014. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts. Biomed Res Int. 2014:954781.
   PubMedGoogle Scholar
• Morita Y, Kataoka A, Shiota S, Mizushima T, Tsuchiya T. 2000. NorM of Vibrio parahaemolyticus is an Na(+)-driven multidrug efflux pump. J Bacteriol. 182:6694–6697.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Ross DD. 2012. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer. 31:73–99.
   PubMed Web of Science ®Google Scholar
• Nambaru, P K, Hübner, T, Köck, K, Mews, S, Grube, M, Payen, L, Guitton, J, Sendler, M, Jedlitschky, G, Rimmbach, C, et al. 2011. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Drug Metab Dispos. 39:132–139. 20930123 10.1124/dmd.110.033613
   PubMed Web of Science ®Google Scholar
• Natarajan K, Xie Y, Baer MR, Ross DD. 2012. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol. 83:1084–1103.
   PubMed Web of Science ®Google Scholar
• Neyfakh AA. 2002. Mystery of multidrug transporters: the answer can be simple. Mol Microbiol. 44:1123–1130.
   PubMed Web of Science ®Google Scholar
• Ni Z, Bikadi Z, Rosenberg MF, Mao Q. 2010. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab. 11:603–617.
   PubMed Web of Science ®Google Scholar
• Nikaido H, Zgurskaya HI. 2001. AcrAB and related multidrug efflux pumps of Escherichia coli. J Mol Microbiol Biotechnol. 3:215–218.
   PubMed Web of Science ®Google Scholar
• Noguchi K, Katayama K, Sugimoto Y. 2014. Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics. Pharmgenomics Pers Med. 7:53–64.
   PubMedGoogle Scholar
• Oba T, Izumi H, Ito K. 2016. ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines. Oncotarget. 7:70011–70027.
   PubMedGoogle Scholar
• Ohene-Agyei T, Mowla R, Rahman T, Venter H. 2014. Phytochemicals increase the antibacterial activity of antibiotics by acting on a drug efflux pump. Microbiologyopen. 3:885–896.
   PubMed Web of Science ®Google Scholar
• Otręebska-Machaj E, Chevalier J, Handzlik J, Szymańska E, Schabikowski J, Boyer G, Bolla J-M, Kieć-Kononowicz K, Pagès J-M, Alibert S. 2016. Efflux pump blockers in Gram-negative bacteria: the new generation of hydantoin based-modulators to improve antibiotic activity. Front Microbiol. 7:622.
   PubMed Web of Science ®Google Scholar
• Padwal P, Bandyopadhyaya R, Mehra S. 2014. Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria. Langmuir. 30:15266–15276.
   PubMed Web of Science ®Google Scholar
• Pasca MR, Guglierame P, Arcesi F, Bellinzoni M, De Rossi E, Riccardi G. 2004. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 48:3175–3178.
   PubMed Web of Science ®Google Scholar
• Persidis A. 1999. Cancer multidrug resistance. Nat Biotechnol. 17:94–95.
   PubMed Web of Science ®Google Scholar
• Pignanelli C, Ma D, Noel M, Ropat J, Mansour F, Curran C, Pupulin S, Larocque K, Wu J, Liang G, et al. 2017. Selective targeting of cancer cells by oxidative vulnerabilities with novel curcumin analogs. Sci Rep. 7:1105.
   PubMed Web of Science ®Google Scholar
• Poelarends GJ, Mazurkiewicz P, Konings WN. 2002. Multidrug transporters and antibiotic resistance in Lactococcus lactis. Biochim Biophys Acta – Bioenerg. 1555:1–7.
   Web of Science ®Google Scholar
• Pule CM, Sampson SL, Warren RM, Black PA, van Helden PD, Victor TC, Louw GE. 2016. Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy. J Antimicrob Chemother. 71:17–26.
   PubMed Web of Science ®Google Scholar
• Radchenko M, Symersky J, Nie R, Lu M. 2015. Structural basis for the blockade of MATE multidrug efflux pumps. Nat Commun. 6:7995.
   PubMed Web of Science ®Google Scholar
• Raghava KM, Lakshmi PK. 2012. Overview of P-glycoprotein inhibitors: a rational outlook. Braz J Pharm Sci. 48:353–367.
   Web of Science ®Google Scholar
• Ranjbar S, Khonkarn R, Moreno A, Baubichon-Cortay H, Miri R, Khoshneviszadeh M, Saso L, Edraki N, Falson P, Firuzi O. 2019. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells. Toxicol Appl Pharmacol. 362:136–149.
   PubMed Web of Science ®Google Scholar
• Rath SK, Singh S, Kumar S, Wani NA, Rai R, Koul S, Khan IA, Sangwan PL. 2019. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus. Bioorg Med Chem. 27:343–353.
   PubMed Web of Science ®Google Scholar
• Reuter G, Janvilisri T, Venter H, Shahi S, Balakrishnan L, van Veen HW. 2003. The ATP binding cassette multidrug transporter LmrA and lipid transporter MsbA have overlapping substrate specificities. J Biol Chem. 278:35193–35198.
   PubMed Web of Science ®Google Scholar
• Rodrigues L, Villellas C, Bailo R, Viveiros M, Ainsa JA. 2013. Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 57:751–757.
   Google Scholar
• Rodzinski A, Guduru R, Liang P, Hadjikhani A, Stewart T, Stimphil E, Runowicz C, Cote R, Altman N, Datar R, et al. 2016. Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles. Sci Rep. 6:20867.
   PubMed Web of Science ®Google Scholar
• Rouquette-Loughlin C, Dunham SA, Kuhn M, Balthazar JT, Shafer WM. 2003. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J Bacteriol. 185:1101–1106.
   PubMed Web of Science ®Google Scholar
• Ruff P, Vorobiof DA, Jordaan JP, Demetriou GS, Moodley SD, Nosworthy AL, Werner ID, Raats J, Burgess LJ. 2009. A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen. Cancer Chemother Pharmacol. 64:763–768.
   PubMed Web of Science ®Google Scholar
• Sabatini S, Gosetto F, Iraci N, Barreca ML, Massari S, Sancineto L, Manfroni G, Tabarrini O, Dimovska M, Kaatz GW, et al. 2013. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance. J Med Chem. 56:4975–4989.
   PubMed Web of Science ®Google Scholar
• Sabatini S, Gosetto F, Manfroni G, Tabarrini O, Kaatz GW, Patel D, Cecchetti V. 2011. Evolution from a natural flavones nucleus to obtain 2-(4-propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. J Med Chem. 54:5722–5736.
   PubMed Web of Science ®Google Scholar
• Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A. 2008. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. J Med Chem. 51:4321–4330.
   PubMed Web of Science ®Google Scholar
• Schmitz FJ, Fluit AC, Luckefahr M, Engler B, Hofmann B, Verhoef J, Heinz HP, Hadding U, Jones ME. 1998. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother. 42:807–810.
   PubMed Web of Science ®Google Scholar
• Shadidi M, Sioud M. 2003. Selective targeting of cancer cells using synthetic peptides. Drug Resist Update. 6:363–371.
   PubMed Web of Science ®Google Scholar
• Shi X, Dou Y, Zhou K, Huo J, Yang T, Qin T, Liu W, Wang S, Yang D, Chang L, et al. 2017. Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line. Biomed Pharmacother. 90:897–905.
   PubMed Web of Science ®Google Scholar
• Shiu WKP, Malkinson JP, Rahman MM, Curry J, Stapleton P, Gunaratnam M, Neidle S, Mushtaq S, Warner M, Livermore DM, et al. 2013. A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus. Int J Antimicrob Agents. 42:513–518.
   PubMed Web of Science ®Google Scholar
• Silver RP, Prior K, Nsahlai C, Wright LF. 2001. ABC transporters and the export of capsular polysaccharides from Gram-negative bacteria. Res Microbiol. 152:357–364.
   PubMed Web of Science ®Google Scholar
• Singh S, Kalia NP, Joshi P, Kumar A, Sharma PR, Kumar A, Bharate SB, Khan IA. 2017. Boeravinone B, A novel dual inhibitor of NorA bacterial efflux pump of Staphylococcus aureus and Human P-Glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria. Front Microbiol. 8:1–12.
   PubMed Web of Science ®Google Scholar
• Sousa D, Lima RT, Vasconcelos MH. 2015. Intercellular transfer of cancer drug resistance traits by extracellular vesicles. Trends Mol Med. 21:595–608.
   PubMed Web of Science ®Google Scholar
• Spengler G, Handzlik J, Ocsovszki I, Viveiros M, Kiec-Kononowicz K, Molnar J, Amaral L. 2011. Modulation of multidrug efflux pump activity by new hydantoin derivatives on colon adenocarcinoma cells without inducing apoptosis. Anticancer Res. 31:3285–3288.
   PubMed Web of Science ®Google Scholar
• Steinfels E, Orelle C, Fantino JR, Dalmas O, Rigaud JL, Denizot F, Di Pietro A, Jault JM. 2004. Characterization of YvcC (BmrA), a multidrug ABC transporter constitutively expressed in Bacillus subtilis. Biochemistry. 43:7491–7502.
   PubMed Web of Science ®Google Scholar
• Stordal B, Hamon M, McEneaney V, Roche S, Gillet J-P, O’Leary JJ, Gottesman M, Clynes M. 2012. Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein. PLoS One. 7:e40717.
   PubMed Web of Science ®Google Scholar
• Suaisom C, Srimanote P, Siriyong T, Tipmanee V, Chusri S, Voravuthikunchai SP, Yingyongnarongkul B. 2017. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa. BMC Complement Alternat Med. 17:405.
   PubMed Web of Science ®Google Scholar
• Sundaramoorthy NS, Mohan HH, Subramanian S, Raman T, Ganesan SS, Sivasubramanian A, Nagarajan S. 2019. Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae. AMB Expr. 9:27.
   PubMed Web of Science ®Google Scholar
• Sun J, Deng Z, Yan A. 2014. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations. Biochem Biophys Res Commun. 453:254–267.
   PubMed Web of Science ®Google Scholar
• Syed SB, Arya H, Fu I-H, Yeh T-K, Periyasamy L, Hsieh H-P, Coumar MS. 2017. Targeting P-glycoprotein: investigation of piperine analogs for overcoming drug resistance in cancer. Sci Rep. 7:7972.
   PubMed Web of Science ®Google Scholar
• Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. 2006. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 5:219–234.
   PubMed Web of Science ®Google Scholar
• Tan KW, Cooney J, Jensen D, Li Y, Paxton JW, Birch NP, Scheepens A. 2014. Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Mol Nutr Food Res. 58:2099–2110.
   PubMed Web of Science ®Google Scholar
• Teodori E, Dei S, Martelli C, Scapecchi S, Gualtieri F. 2006. The functions and structure of ABC transporters: implications for the design of new inhibitors of P-gp and MRP1 to control multidrug resistance (MDR). CDT Targets. 7:893–909.
   Google Scholar
• Tintino SR, Oliveira-Tintino CDM, Campina FF, Silva RLP, Costa M. d S, Menezes IRA, Calixto-Júnior JT, Siqueira-Junior JP, Coutinho HDM, Leal-Balbino TC, et al. 2016. Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus. Microb Pathog. 97:9–13.
   PubMed Web of Science ®Google Scholar
• Tomiyasu H, Watanabe M, Sugita K, Goto-Koshino Y, Fujino Y, Ohno K, Sugano S, Tsujimoto H. 2013. Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines. Anticancer Res. 33:5317–5323.
   PubMed Web of Science ®Google Scholar
• Ughachukwu P, Unekwe P. 2012. Efflux pump-mediated resistance in chemotherapy. Ann Med Health Sci Res. 2:191–198.
   PubMedGoogle Scholar
• Vasiliou V, Vasiliou K, Nebert DW. 2009. Human ATP-binding cassette (ABC) transporter family. Hum Genomics. 3:281–290.
   PubMedGoogle Scholar
• van Veen HW, Callaghan R, Soceneantu L, Sardini A, Konings WN, Higgins CF. 1998. A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature. 391:291–295.
   PubMed Web of Science ®Google Scholar
• van Veen HW, Konings WN. 1997. Multidrug transporters from bacteria to man: similarities in structure and function. Semin Cancer Biol. 8:183–191.
   PubMed Web of Science ®Google Scholar
• Velamakanni S, Yao Y, Gutmann DAP, Van Veen HW. 2008. Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus. Biochemistry. 47:9300–9308.
   PubMed Web of Science ®Google Scholar
• Wang W, Guo Q, Xu X, Sheng Z.-K, Ye X, Wang M. 2014. High-level tetracycline resistance mediated by efflux pumps Tet(A) and Tet(A)-1 with two start codons. J Med Microbiol. 63:1454–1459.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Yang S, Yang L. 2005. Classification of substrates and inhibitors of P-glycoprotein using unsupervised machine learning approach. J Chem Inf Model. 45:750–757.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang L, Xia Y, Guo C, Kong L. 2015. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway. Biol Pharm Bull. 38:277–284.
   PubMed Web of Science ®Google Scholar
• Wen P-C, Verhalen B, Wilkens S, Mchaourab HS, Tajkhorshid E. 2013. On the origin of large flexibility of P-glycoprotein in the inward-facing state. J Biol Chem. 288:19211–19220.
   PubMed Web of Science ®Google Scholar
• Wesołowska O, Molnar J, Ocsovszki I, Michalak K. 2009. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity. In Vivo. 23:943–947.
   PubMed Web of Science ®Google Scholar
• Wilkens S. 2004. Structure and mechanism of ABC transporters. Curr Opin Struct Biol. 14:426–431.
   PubMed Web of Science ®Google Scholar
• Willis LM, Whitfield C. 2013. Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by ABC transporter-dependent pathways. Carbohydr Res. 378:35–44.
   PubMed Web of Science ®Google Scholar
• Wink M, Ashour ML, El-Readi MZ. 2012. Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents. Front Microbiol. 3:130.
   PubMed Web of Science ®Google Scholar
• Wong K, Ma J, Rothnie A, Biggin PC, Kerr ID. 2014. Towards understanding promiscuity in multidrug efflux pumps. Trends Biochem Sci. 39:8–16.
   PubMed Web of Science ®Google Scholar
• Woolley RC, Vediyappan G, Anderson M, Lackey M, Ramasubramanian B, Jiangping B, Borisova T, Colmer JA, Hamood AN, McVay CS, et al. 2005. Characterization of the Vibrio cholerae vceCAB multiple-drug resistance efflux operon in Escherichia coli. J Bacteriol. 187:5500–5503.
   PubMed Web of Science ®Google Scholar
• Wu CP, Hsieh CH, Hsiao SH, Luo SY, Su CY, Li YQ, Huang YH, Huang CW, Hsu SC. 2015. Human ATP-binding cassette transporter ABCB1 confers resistance to volasertib (BI 6727), a selective inhibitor of polo-like kinase 1. Mol Pharm. 12:3885–3895.
   PubMedGoogle Scholar
• Yang H, Duan G, Zhu J, Lv R, Xi Y, Zhang W, Fan Q, Zhang M. 2008. The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates. Microb Drug Resist. 14:245–249.
   PubMed Web of Science ®Google Scholar
• Yang X, Yang P, Shen J, Osaka E, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, et al. 2014. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925. Br J Cancer. 110:2896–2904.
   PubMed Web of Science ®Google Scholar
• Yerushalmi H, Lebendiker M, Schuldiner S. 1995. EmrE, an Escherichia coli 12-kDa multidrug transporter, exchanges toxic cations and H+ and is soluble in organic solvents. J Biol Chem. 270:6856–6863.
   PubMed Web of Science ®Google Scholar
• Yoshikai H, Kizaki H, Saito Y, Omae Y, Sekimizu K, Kaito C. 2016. Multidrug-resistance transporter AbcA secretes Staphylococcus aureus cytolytic toxins. J Infect Dis. 213:295–304.
   PubMed Web of Science ®Google Scholar
• Zaidi AH, Bakkes PJ, Lubelski J, Agustiandari H, Kuipers OP, Driessen A. 2008. The ABC-type multidrug resistance transporter LmrCD is responsible for an extrusion-based mechanism of bile acid resistance in Lactococcus lactis. J Bacteriol. 190:7357–7366.
   PubMed Web of Science ®Google Scholar
• Żesławska E, Kincses A, Spengler G, Nitek W, Wyrzuc K, Kieć-Kononowicz K, Handzlik J. 2016. The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): synthesis, crystallographic and biological studies. Bioorg Med Chem. 24:2815–2822.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhu Y, Zhao Q, Yang D, Dong Y, Jiang L, Xing W, Li X, Xing H, Shi M, et al. 2014. Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance. Eur J Pharmacol. 738:83–90.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng L, Liu P, Duan W. 2018. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer. Biosci Rep. 38:BSR20180620.
   PubMed Web of Science ®Google Scholar
• Zhou S, Schuetz JD, Bunting KD, Colapietro A-M, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, et al. 2001. The ABC transporter BCRP1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 7:1028–1034.
   PubMed Web of Science ®Google Scholar
• Zhou X, Wang Y, Lee WYW, Or PMY, Wan DCC, Kwan YW, Yeung J. 2015. Miltirone is a dual inhibitor of P-glycoprotein and cell growth in doxorubicin-resistant HepG2 cells. J Nat Prod. 78:2266–2275.
   PubMed Web of Science ®Google Scholar